nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—obesity—hypertension	0.247	1	CtDrD
Methamphetamine—attention deficit hyperactivity disorder—Guanfacine—hypertension	0.116	0.697	CpDpCtD
Methamphetamine—ADRA2B—hypertension	0.0516	0.323	CbGaD
Methamphetamine—attention deficit hyperactivity disorder—Clonidine—hypertension	0.0505	0.303	CpDpCtD
Methamphetamine—SLC18A1—Reserpine—hypertension	0.0479	0.246	CbGbCtD
Methamphetamine—SLC6A2—hypertension	0.0453	0.284	CbGaD
Methamphetamine—SLC6A3—hypertension	0.023	0.144	CbGaD
Methamphetamine—ADRA2A—hypertension	0.0226	0.141	CbGaD
Methamphetamine—SLC6A4—hypertension	0.0172	0.108	CbGaD
Methamphetamine—Phenacemide—Guanfacine—hypertension	0.0171	0.126	CrCrCtD
Methamphetamine—SLC18A2—Reserpine—hypertension	0.0148	0.0761	CbGbCtD
Methamphetamine—Lisdexamfetamine—Labetalol—hypertension	0.0132	0.0972	CrCrCtD
Methamphetamine—Aspartame—Quinapril—hypertension	0.0129	0.0952	CrCrCtD
Methamphetamine—Nateglinide—Trandolapril—hypertension	0.0112	0.0825	CrCrCtD
Methamphetamine—Nateglinide—Enalapril—hypertension	0.0112	0.0825	CrCrCtD
Methamphetamine—Aspartame—Enalapril—hypertension	0.0106	0.0784	CrCrCtD
Methamphetamine—Aspartame—Trandolapril—hypertension	0.0106	0.0784	CrCrCtD
Methamphetamine—Lisdexamfetamine—Lisinopril—hypertension	0.00984	0.0724	CrCrCtD
Methamphetamine—SLC6A2—Guanadrel—hypertension	0.0094	0.0482	CbGbCtD
Methamphetamine—Nateglinide—Lisinopril—hypertension	0.00877	0.0646	CrCrCtD
Methamphetamine—Nateglinide—Ramipril—hypertension	0.0085	0.0626	CrCrCtD
Methamphetamine—Aspartame—Lisinopril—hypertension	0.00833	0.0613	CrCrCtD
Methamphetamine—Aspartame—Ramipril—hypertension	0.00807	0.0594	CrCrCtD
Methamphetamine—SLC6A2—Guanethidine—hypertension	0.00713	0.0365	CbGbCtD
Methamphetamine—ADRA2C—Guanabenz—hypertension	0.00675	0.0346	CbGbCtD
Methamphetamine—ADRA2B—Guanabenz—hypertension	0.0064	0.0328	CbGbCtD
Methamphetamine—SLC22A3—Prazosin—hypertension	0.00598	0.0306	CbGbCtD
Methamphetamine—ADRA2B—Guanfacine—hypertension	0.00595	0.0305	CbGbCtD
Methamphetamine—ADRA2C—Fenoldopam—hypertension	0.00534	0.0274	CbGbCtD
Methamphetamine—Benzphetamine—Bepridil—hypertension	0.00533	0.0393	CrCrCtD
Methamphetamine—ADRA2B—Fenoldopam—hypertension	0.00506	0.026	CbGbCtD
Methamphetamine—ADRA2A—Methyldopa—hypertension	0.00487	0.025	CbGbCtD
Methamphetamine—SLC22A3—Clonidine—hypertension	0.00453	0.0232	CbGbCtD
Methamphetamine—ADRA2A—Guanabenz—hypertension	0.00445	0.0228	CbGbCtD
Methamphetamine—ADRA2A—Guanfacine—hypertension	0.00414	0.0212	CbGbCtD
Methamphetamine—ADRA2B—Prazosin—hypertension	0.00384	0.0197	CbGbCtD
Methamphetamine—ADRA2A—Fenoldopam—hypertension	0.00352	0.0181	CbGbCtD
Methamphetamine—ADRA2C—Carvedilol—hypertension	0.00349	0.0179	CbGbCtD
Methamphetamine—ADRA2B—Carvedilol—hypertension	0.00331	0.017	CbGbCtD
Methamphetamine—ADRA2A—Doxazosin—hypertension	0.00325	0.0167	CbGbCtD
Methamphetamine—ADRA2C—Clonidine—hypertension	0.00306	0.0157	CbGbCtD
Methamphetamine—ADRA2B—Clonidine—hypertension	0.00291	0.0149	CbGbCtD
Methamphetamine—SLC22A5—Clonidine—hypertension	0.00281	0.0144	CbGbCtD
Methamphetamine—ADRA2A—Prazosin—hypertension	0.00267	0.0137	CbGbCtD
Methamphetamine—SLC22A5—Furosemide—hypertension	0.00234	0.012	CbGbCtD
Methamphetamine—ADRA2A—Carvedilol—hypertension	0.0023	0.0118	CbGbCtD
Methamphetamine—SLC6A2—Clonidine—hypertension	0.00224	0.0115	CbGbCtD
Methamphetamine—SLC22A5—Verapamil—hypertension	0.00202	0.0104	CbGbCtD
Methamphetamine—ADRA2A—Clonidine—hypertension	0.00202	0.0104	CbGbCtD
Methamphetamine—SLC6A4—Verapamil—hypertension	0.00193	0.00989	CbGbCtD
Methamphetamine—CYP2D6—Labetalol—hypertension	0.00162	0.0083	CbGbCtD
Methamphetamine—CYP2D6—Nebivolol—hypertension	0.00162	0.0083	CbGbCtD
Methamphetamine—CYP2D6—Acebutolol—hypertension	0.00148	0.00759	CbGbCtD
Methamphetamine—CYP2D6—Metoprolol—hypertension	0.00138	0.00706	CbGbCtD
Methamphetamine—CYP2D6—Pindolol—hypertension	0.00138	0.00706	CbGbCtD
Methamphetamine—CYP2D6—Betaxolol—hypertension	0.00123	0.00629	CbGbCtD
Methamphetamine—CYP2D6—Doxazosin—hypertension	0.00108	0.00554	CbGbCtD
Methamphetamine—CYP2D6—Diltiazem—hypertension	0.00104	0.00535	CbGbCtD
Methamphetamine—SLC6A2—locus ceruleus—hypertension	0.000952	0.0752	CbGeAlD
Methamphetamine—CYP2D6—Bepridil—hypertension	0.00093	0.00477	CbGbCtD
Methamphetamine—MAOA—locus ceruleus—hypertension	0.000877	0.0693	CbGeAlD
Methamphetamine—CYP2D6—Irbesartan—hypertension	0.000851	0.00436	CbGbCtD
Methamphetamine—CYP2D6—Amlodipine—hypertension	0.000834	0.00428	CbGbCtD
Methamphetamine—CYP2D6—Felodipine—hypertension	0.000804	0.00412	CbGbCtD
Methamphetamine—CYP2D6—Timolol—hypertension	0.000791	0.00406	CbGbCtD
Methamphetamine—CYP2D6—Nifedipine—hypertension	0.000778	0.00399	CbGbCtD
Methamphetamine—CYP2D6—Carvedilol—hypertension	0.000766	0.00393	CbGbCtD
Methamphetamine—CYP2D6—Nicardipine—hypertension	0.000766	0.00393	CbGbCtD
Methamphetamine—SLC6A2—sympathetic nervous system—hypertension	0.000753	0.0594	CbGeAlD
Methamphetamine—CYP2D6—Propranolol—hypertension	0.000705	0.00361	CbGbCtD
Methamphetamine—CYP2D6—Captopril—hypertension	0.000696	0.00357	CbGbCtD
Methamphetamine—CYP2D6—Clonidine—hypertension	0.000672	0.00345	CbGbCtD
Methamphetamine—CYP2D6—Atorvastatin—hypertension	0.000599	0.00307	CbGbCtD
Methamphetamine—SLC6A2—autonomic nervous system—hypertension	0.000506	0.0399	CbGeAlD
Methamphetamine—CYP2D6—Verapamil—hypertension	0.000484	0.00248	CbGbCtD
Methamphetamine—SLC18A1—adrenal gland—hypertension	0.000405	0.0319	CbGeAlD
Methamphetamine—SLC18A1—endocrine gland—hypertension	0.000351	0.0277	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—hypertension	0.000316	0.025	CbGeAlD
Methamphetamine—TAAR1—central nervous system—hypertension	0.000297	0.0235	CbGeAlD
Methamphetamine—CYP2D6—urine—hypertension	0.000226	0.0178	CbGeAlD
Methamphetamine—SLC18A2—brainstem—hypertension	0.0002	0.0158	CbGeAlD
Methamphetamine—MAOB—cardiac ventricle—hypertension	0.000174	0.0137	CbGeAlD
Methamphetamine—MAOB—myocardium—hypertension	0.000163	0.0129	CbGeAlD
Methamphetamine—Bethanidine—KCNJ1—hypertension	0.000152	0.0928	CrCbGaD
Methamphetamine—SLC6A3—brainstem—hypertension	0.000151	0.012	CbGeAlD
Methamphetamine—MAOA—cardiac ventricle—hypertension	0.000148	0.0117	CbGeAlD
Methamphetamine—ADRA2C—cardiac ventricle—hypertension	0.000143	0.0113	CbGeAlD
Methamphetamine—SLC18A2—medulla oblongata—hypertension	0.00014	0.011	CbGeAlD
Methamphetamine—MAOA—myocardium—hypertension	0.000139	0.011	CbGeAlD
Methamphetamine—SLC6A4—brainstem—hypertension	0.000139	0.011	CbGeAlD
Methamphetamine—SLC22A5—cardiac ventricle—hypertension	0.000137	0.0108	CbGeAlD
Methamphetamine—ADRA2C—myocardium—hypertension	0.000134	0.0106	CbGeAlD
Methamphetamine—MAOB—brainstem—hypertension	0.000132	0.0104	CbGeAlD
Methamphetamine—SLC18A2—adrenal gland—hypertension	0.000129	0.0102	CbGeAlD
Methamphetamine—SLC22A5—myocardium—hypertension	0.000128	0.0101	CbGeAlD
Methamphetamine—SLC22A3—smooth muscle tissue—hypertension	0.000122	0.00966	CbGeAlD
Methamphetamine—SLC6A2—brainstem—hypertension	0.000122	0.00965	CbGeAlD
Methamphetamine—MAOB—nephron tubule—hypertension	0.00012	0.00946	CbGeAlD
Methamphetamine—MAOB—adrenal cortex—hypertension	0.000118	0.00931	CbGeAlD
Methamphetamine—MAOB—heart—hypertension	0.000114	0.00901	CbGeAlD
Methamphetamine—SLC22A3—kidney—hypertension	0.000114	0.00899	CbGeAlD
Methamphetamine—MAOA—brainstem—hypertension	0.000113	0.00889	CbGeAlD
Methamphetamine—SLC18A2—endocrine gland—hypertension	0.000112	0.00885	CbGeAlD
Methamphetamine—MAOB—decidua—hypertension	0.000111	0.00876	CbGeAlD
Methamphetamine—MAOB—cardiovascular system—hypertension	0.000108	0.0085	CbGeAlD
Methamphetamine—MAOB—kidney—hypertension	0.000105	0.00832	CbGeAlD
Methamphetamine—Phenformin—KCNJ8—hypertension	0.000104	0.0636	CrCbGaD
Methamphetamine—SLC6A2—decidua—hypertension	0.000103	0.00811	CbGeAlD
Methamphetamine—MAOB—cortex of kidney—hypertension	0.000103	0.0081	CbGeAlD
Methamphetamine—MAOA—nephron tubule—hypertension	0.000102	0.00807	CbGeAlD
Methamphetamine—SLC18A2—central nervous system—hypertension	0.000101	0.00797	CbGeAlD
Methamphetamine—MAOA—adrenal cortex—hypertension	0.000101	0.00795	CbGeAlD
Methamphetamine—ADRA2C—nephron tubule—hypertension	9.83e-05	0.00776	CbGeAlD
Methamphetamine—MAOB—cardiac atrium—hypertension	9.76e-05	0.0077	CbGeAlD
Methamphetamine—MAOA—heart—hypertension	9.74e-05	0.00769	CbGeAlD
Methamphetamine—ADRA2C—adrenal cortex—hypertension	9.68e-05	0.00764	CbGeAlD
Methamphetamine—MAOA—decidua—hypertension	9.47e-05	0.00748	CbGeAlD
Methamphetamine—SLC22A5—nephron tubule—hypertension	9.42e-05	0.00744	CbGeAlD
Methamphetamine—ADRA2C—heart—hypertension	9.36e-05	0.00739	CbGeAlD
Methamphetamine—SLC22A5—adrenal cortex—hypertension	9.27e-05	0.00732	CbGeAlD
Methamphetamine—SLC22A3—adrenal gland—hypertension	9.2e-05	0.00727	CbGeAlD
Methamphetamine—MAOB—medulla oblongata—hypertension	9.2e-05	0.00726	CbGeAlD
Methamphetamine—MAOA—cardiovascular system—hypertension	9.19e-05	0.00725	CbGeAlD
Methamphetamine—ADRA2C—decidua—hypertension	9.1e-05	0.00719	CbGeAlD
Methamphetamine—MAOA—kidney—hypertension	8.99e-05	0.0071	CbGeAlD
Methamphetamine—SLC22A5—heart—hypertension	8.97e-05	0.00708	CbGeAlD
Methamphetamine—MAOA—cortex of kidney—hypertension	8.75e-05	0.00691	CbGeAlD
Methamphetamine—ADRA2C—kidney—hypertension	8.64e-05	0.00682	CbGeAlD
Methamphetamine—SLC6A2—medulla oblongata—hypertension	8.52e-05	0.00673	CbGeAlD
Methamphetamine—MAOB—adrenal gland—hypertension	8.52e-05	0.00672	CbGeAlD
Methamphetamine—ADRA2C—cortex of kidney—hypertension	8.42e-05	0.00664	CbGeAlD
Methamphetamine—MAOA—cardiac atrium—hypertension	8.33e-05	0.00657	CbGeAlD
Methamphetamine—SLC22A5—kidney—hypertension	8.28e-05	0.00654	CbGeAlD
Methamphetamine—SLC22A5—cortex of kidney—hypertension	8.06e-05	0.00636	CbGeAlD
Methamphetamine—ADRA2C—cardiac atrium—hypertension	8.01e-05	0.00632	CbGeAlD
Methamphetamine—SLC22A3—endocrine gland—hypertension	7.98e-05	0.0063	CbGeAlD
Methamphetamine—SLC6A2—adrenal gland—hypertension	7.89e-05	0.00623	CbGeAlD
Methamphetamine—MAOA—medulla oblongata—hypertension	7.85e-05	0.0062	CbGeAlD
Methamphetamine—SLC6A4—endocrine gland—hypertension	7.77e-05	0.00613	CbGeAlD
Methamphetamine—SLC22A5—cardiac atrium—hypertension	7.67e-05	0.00605	CbGeAlD
Methamphetamine—SLC6A3—central nervous system—hypertension	7.64e-05	0.00603	CbGeAlD
Methamphetamine—ADRA2C—medulla oblongata—hypertension	7.55e-05	0.00596	CbGeAlD
Methamphetamine—ADRA2A—heart—hypertension	7.47e-05	0.0059	CbGeAlD
Methamphetamine—MAOB—endocrine gland—hypertension	7.39e-05	0.00583	CbGeAlD
Methamphetamine—MAOA—adrenal gland—hypertension	7.27e-05	0.00574	CbGeAlD
Methamphetamine—ADRA2A—decidua—hypertension	7.26e-05	0.00574	CbGeAlD
Methamphetamine—SLC22A5—medulla oblongata—hypertension	7.23e-05	0.00571	CbGeAlD
Methamphetamine—SLC22A3—central nervous system—hypertension	7.19e-05	0.00568	CbGeAlD
Methamphetamine—Diethylpropion—SLC6A2—hypertension	7.09e-05	0.0434	CrCbGaD
Methamphetamine—SLC6A4—central nervous system—hypertension	7e-05	0.00553	CbGeAlD
Methamphetamine—ADRA2C—adrenal gland—hypertension	6.99e-05	0.00552	CbGeAlD
Methamphetamine—SLC6A2—endocrine gland—hypertension	6.84e-05	0.0054	CbGeAlD
Methamphetamine—ADRA2A—cortex of kidney—hypertension	6.72e-05	0.0053	CbGeAlD
Methamphetamine—SLC22A5—adrenal gland—hypertension	6.69e-05	0.00528	CbGeAlD
Methamphetamine—CYP2D6—brainstem—hypertension	6.69e-05	0.00528	CbGeAlD
Methamphetamine—MAOB—central nervous system—hypertension	6.66e-05	0.00525	CbGeAlD
Methamphetamine—Dexfenfluramine—HTR2B—hypertension	6.56e-05	0.0401	CrCbGaD
Methamphetamine—ADRA2A—cardiac atrium—hypertension	6.39e-05	0.00504	CbGeAlD
Methamphetamine—MAOA—endocrine gland—hypertension	6.3e-05	0.00497	CbGeAlD
Methamphetamine—Bethanidine—SLC6A2—hypertension	6.22e-05	0.0381	CrCbGaD
Methamphetamine—SLC6A2—central nervous system—hypertension	6.16e-05	0.00487	CbGeAlD
Methamphetamine—ADRA2A—medulla oblongata—hypertension	6.02e-05	0.00475	CbGeAlD
Methamphetamine—MAOA—central nervous system—hypertension	5.68e-05	0.00448	CbGeAlD
Methamphetamine—Mephentermine—ADRA1A—hypertension	5.66e-05	0.0346	CrCbGaD
Methamphetamine—ADRA2A—adrenal gland—hypertension	5.58e-05	0.0044	CbGeAlD
Methamphetamine—ADRA2C—central nervous system—hypertension	5.46e-05	0.00431	CbGeAlD
Methamphetamine—Lisdexamfetamine—SLC6A2—hypertension	5.37e-05	0.0329	CrCbGaD
Methamphetamine—CYP2D6—kidney—hypertension	5.34e-05	0.00422	CbGeAlD
Methamphetamine—Phenelzine—ABAT—hypertension	4.93e-05	0.0301	CrCbGaD
Methamphetamine—Tolazoline—ADRA2B—hypertension	4.91e-05	0.03	CrCbGaD
Methamphetamine—Gastrointestinal disorder—Diltiazem—hypertension	4.84e-05	0.00121	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Indapamide—hypertension	4.84e-05	0.00121	CcSEcCtD
Methamphetamine—Insomnia—Nifedipine—hypertension	4.84e-05	0.00121	CcSEcCtD
Methamphetamine—Dyspepsia—Doxazosin—hypertension	4.84e-05	0.00121	CcSEcCtD
Methamphetamine—ADRA2A—endocrine gland—hypertension	4.83e-05	0.00382	CbGeAlD
Methamphetamine—Insomnia—Verapamil—hypertension	4.82e-05	0.0012	CcSEcCtD
Methamphetamine—Tachycardia—Olmesartan—hypertension	4.82e-05	0.0012	CcSEcCtD
Methamphetamine—Agitation—Perindopril—hypertension	4.82e-05	0.0012	CcSEcCtD
Methamphetamine—Headache—Felodipine—hypertension	4.81e-05	0.0012	CcSEcCtD
Methamphetamine—Headache—Metolazone—hypertension	4.81e-05	0.0012	CcSEcCtD
Methamphetamine—Agitation—Irbesartan—hypertension	4.8e-05	0.0012	CcSEcCtD
Methamphetamine—Constipation—Indapamide—hypertension	4.8e-05	0.0012	CcSEcCtD
Methamphetamine—Constipation—Diltiazem—hypertension	4.8e-05	0.0012	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Carvedilol—hypertension	4.8e-05	0.0012	CcSEcCtD
Methamphetamine—Headache—Spironolactone—hypertension	4.79e-05	0.0012	CcSEcCtD
Methamphetamine—Dyspepsia—Fosinopril—hypertension	4.78e-05	0.00119	CcSEcCtD
Methamphetamine—Palpitations—Captopril—hypertension	4.77e-05	0.00119	CcSEcCtD
Methamphetamine—Dizziness—Acebutolol—hypertension	4.76e-05	0.00119	CcSEcCtD
Methamphetamine—Agitation—Hydrochlorothiazide—hypertension	4.76e-05	0.00119	CcSEcCtD
Methamphetamine—Constipation—Carvedilol—hypertension	4.75e-05	0.00119	CcSEcCtD
Methamphetamine—Dyspepsia—Eplerenone—hypertension	4.75e-05	0.00119	CcSEcCtD
Methamphetamine—Diarrhoea—Eprosartan—hypertension	4.73e-05	0.00118	CcSEcCtD
Methamphetamine—Tremor—Betaxolol—hypertension	4.73e-05	0.00118	CcSEcCtD
Methamphetamine—Dizziness—Labetalol—hypertension	4.72e-05	0.00118	CcSEcCtD
Methamphetamine—Dyspepsia—Nifedipine—hypertension	4.71e-05	0.00118	CcSEcCtD
Methamphetamine—Constipation—Doxazosin—hypertension	4.7e-05	0.00117	CcSEcCtD
Methamphetamine—Dyspepsia—Verapamil—hypertension	4.69e-05	0.00117	CcSEcCtD
Methamphetamine—Headache—Esmolol—hypertension	4.69e-05	0.00117	CcSEcCtD
Methamphetamine—Agitation—Furosemide—hypertension	4.68e-05	0.00117	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Eplerenone—hypertension	4.66e-05	0.00116	CcSEcCtD
Methamphetamine—Hypersensitivity—Metoprolol—hypertension	4.65e-05	0.00116	CcSEcCtD
Methamphetamine—Hypersensitivity—Guanabenz—hypertension	4.65e-05	0.00116	CcSEcCtD
Methamphetamine—Constipation—Fosinopril—hypertension	4.64e-05	0.00116	CcSEcCtD
Methamphetamine—Palpitations—Perindopril—hypertension	4.63e-05	0.00116	CcSEcCtD
Methamphetamine—Headache—Terazosin—hypertension	4.63e-05	0.00116	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Nifedipine—hypertension	4.62e-05	0.00115	CcSEcCtD
Methamphetamine—Tachycardia—Clonidine—hypertension	4.62e-05	0.00115	CcSEcCtD
Methamphetamine—Constipation—Eplerenone—hypertension	4.61e-05	0.00115	CcSEcCtD
Methamphetamine—Tremor—Losartan—hypertension	4.61e-05	0.00115	CcSEcCtD
Methamphetamine—Urticaria—Propranolol—hypertension	4.6e-05	0.00115	CcSEcCtD
Methamphetamine—Diarrhoea—Nisoldipine—hypertension	4.59e-05	0.00115	CcSEcCtD
Methamphetamine—Diarrhoea—Amlodipine—hypertension	4.59e-05	0.00115	CcSEcCtD
Methamphetamine—Palpitations—Hydrochlorothiazide—hypertension	4.58e-05	0.00114	CcSEcCtD
Methamphetamine—Constipation—Nifedipine—hypertension	4.58e-05	0.00114	CcSEcCtD
Methamphetamine—Dizziness—Eprosartan—hypertension	4.57e-05	0.00114	CcSEcCtD
Methamphetamine—Constipation—Verapamil—hypertension	4.56e-05	0.00114	CcSEcCtD
Methamphetamine—Agitation—Losartan—hypertension	4.52e-05	0.00113	CcSEcCtD
Methamphetamine—Headache—Acebutolol—hypertension	4.51e-05	0.00113	CcSEcCtD
Methamphetamine—Tachycardia—Trandolapril—hypertension	4.5e-05	0.00112	CcSEcCtD
Methamphetamine—Insomnia—Valsartan—hypertension	4.49e-05	0.00112	CcSEcCtD
Methamphetamine—Tachycardia—Enalapril—hypertension	4.49e-05	0.00112	CcSEcCtD
Methamphetamine—Headache—Labetalol—hypertension	4.47e-05	0.00112	CcSEcCtD
Methamphetamine—Insomnia—Olmesartan—hypertension	4.47e-05	0.00112	CcSEcCtD
Methamphetamine—Palpitations—Betaxolol—hypertension	4.46e-05	0.00111	CcSEcCtD
Methamphetamine—Urticaria—Diltiazem—hypertension	4.46e-05	0.00111	CcSEcCtD
Methamphetamine—Urticaria—Indapamide—hypertension	4.46e-05	0.00111	CcSEcCtD
Methamphetamine—Dizziness—Nisoldipine—hypertension	4.44e-05	0.00111	CcSEcCtD
Methamphetamine—Dizziness—Amlodipine—hypertension	4.44e-05	0.00111	CcSEcCtD
Methamphetamine—Tachycardia—Telmisartan—hypertension	4.42e-05	0.0011	CcSEcCtD
Methamphetamine—Urticaria—Carvedilol—hypertension	4.41e-05	0.0011	CcSEcCtD
Methamphetamine—Dyspepsia—Valsartan—hypertension	4.37e-05	0.00109	CcSEcCtD
Methamphetamine—Urticaria—Doxazosin—hypertension	4.36e-05	0.00109	CcSEcCtD
Methamphetamine—ADRA2A—central nervous system—hypertension	4.36e-05	0.00344	CbGeAlD
Methamphetamine—Dyspepsia—Olmesartan—hypertension	4.35e-05	0.00109	CcSEcCtD
Methamphetamine—Palpitations—Losartan—hypertension	4.35e-05	0.00109	CcSEcCtD
Methamphetamine—Headache—Eprosartan—hypertension	4.33e-05	0.00108	CcSEcCtD
Methamphetamine—Diarrhoea—Metoprolol—hypertension	4.32e-05	0.00108	CcSEcCtD
Methamphetamine—Diarrhoea—Guanabenz—hypertension	4.32e-05	0.00108	CcSEcCtD
Methamphetamine—Urticaria—Fosinopril—hypertension	4.31e-05	0.00108	CcSEcCtD
Methamphetamine—Tachycardia—Captopril—hypertension	4.3e-05	0.00107	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Valsartan—hypertension	4.28e-05	0.00107	CcSEcCtD
Methamphetamine—Insomnia—Clonidine—hypertension	4.28e-05	0.00107	CcSEcCtD
Methamphetamine—Hypersensitivity—Propranolol—hypertension	4.27e-05	0.00107	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Olmesartan—hypertension	4.26e-05	0.00107	CcSEcCtD
Methamphetamine—Urticaria—Nifedipine—hypertension	4.25e-05	0.00106	CcSEcCtD
Methamphetamine—Constipation—Valsartan—hypertension	4.24e-05	0.00106	CcSEcCtD
Methamphetamine—Urticaria—Verapamil—hypertension	4.23e-05	0.00106	CcSEcCtD
Methamphetamine—Constipation—Olmesartan—hypertension	4.22e-05	0.00105	CcSEcCtD
Methamphetamine—Headache—Nisoldipine—hypertension	4.21e-05	0.00105	CcSEcCtD
Methamphetamine—Headache—Amlodipine—hypertension	4.21e-05	0.00105	CcSEcCtD
Methamphetamine—Ephedrine—SLC6A2—hypertension	4.2e-05	0.0257	CrCbGaD
Methamphetamine—Tachycardia—Perindopril—hypertension	4.18e-05	0.00104	CcSEcCtD
Methamphetamine—Dizziness—Metoprolol—hypertension	4.17e-05	0.00104	CcSEcCtD
Methamphetamine—Dizziness—Guanabenz—hypertension	4.17e-05	0.00104	CcSEcCtD
Methamphetamine—Insomnia—Trandolapril—hypertension	4.17e-05	0.00104	CcSEcCtD
Methamphetamine—Tachycardia—Irbesartan—hypertension	4.16e-05	0.00104	CcSEcCtD
Methamphetamine—Insomnia—Enalapril—hypertension	4.16e-05	0.00104	CcSEcCtD
Methamphetamine—Hypersensitivity—Indapamide—hypertension	4.13e-05	0.00103	CcSEcCtD
Methamphetamine—Hypersensitivity—Diltiazem—hypertension	4.13e-05	0.00103	CcSEcCtD
Methamphetamine—Tachycardia—Hydrochlorothiazide—hypertension	4.13e-05	0.00103	CcSEcCtD
Methamphetamine—Benzyl alcohol—ALDH2—hypertension	4.1e-05	0.0251	CrCbGaD
Methamphetamine—Insomnia—Telmisartan—hypertension	4.1e-05	0.00102	CcSEcCtD
Methamphetamine—Hypersensitivity—Carvedilol—hypertension	4.09e-05	0.00102	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Clonidine—hypertension	4.08e-05	0.00102	CcSEcCtD
Methamphetamine—Dyspepsia—Trandolapril—hypertension	4.06e-05	0.00101	CcSEcCtD
Methamphetamine—Hypersensitivity—Doxazosin—hypertension	4.05e-05	0.00101	CcSEcCtD
Methamphetamine—Constipation—Clonidine—hypertension	4.05e-05	0.00101	CcSEcCtD
Methamphetamine—Dyspepsia—Enalapril—hypertension	4.05e-05	0.00101	CcSEcCtD
Methamphetamine—Tachycardia—Betaxolol—hypertension	4.02e-05	0.001	CcSEcCtD
Methamphetamine—Hypersensitivity—Fosinopril—hypertension	4e-05	0.000999	CcSEcCtD
Methamphetamine—Dyspepsia—Telmisartan—hypertension	3.99e-05	0.000997	CcSEcCtD
Methamphetamine—Insomnia—Captopril—hypertension	3.99e-05	0.000996	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Trandolapril—hypertension	3.98e-05	0.000995	CcSEcCtD
Methamphetamine—Diarrhoea—Propranolol—hypertension	3.97e-05	0.00099	CcSEcCtD
Methamphetamine—Headache—Guanabenz—hypertension	3.95e-05	0.000987	CcSEcCtD
Methamphetamine—Headache—Metoprolol—hypertension	3.95e-05	0.000987	CcSEcCtD
Methamphetamine—Tremor—Ramipril—hypertension	3.95e-05	0.000987	CcSEcCtD
Methamphetamine—Constipation—Trandolapril—hypertension	3.95e-05	0.000985	CcSEcCtD
Methamphetamine—Hypersensitivity—Nifedipine—hypertension	3.94e-05	0.000985	CcSEcCtD
Methamphetamine—Urticaria—Valsartan—hypertension	3.94e-05	0.000985	CcSEcCtD
Methamphetamine—Constipation—Enalapril—hypertension	3.93e-05	0.000981	CcSEcCtD
Methamphetamine—Hypersensitivity—Verapamil—hypertension	3.93e-05	0.000981	CcSEcCtD
Methamphetamine—Urticaria—Olmesartan—hypertension	3.92e-05	0.00098	CcSEcCtD
Methamphetamine—Tachycardia—Losartan—hypertension	3.92e-05	0.000978	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Telmisartan—hypertension	3.91e-05	0.000977	CcSEcCtD
Methamphetamine—Dyspepsia—Captopril—hypertension	3.88e-05	0.000969	CcSEcCtD
Methamphetamine—Constipation—Telmisartan—hypertension	3.88e-05	0.000968	CcSEcCtD
Methamphetamine—Agitation—Ramipril—hypertension	3.88e-05	0.000968	CcSEcCtD
Methamphetamine—Insomnia—Perindopril—hypertension	3.87e-05	0.000967	CcSEcCtD
Methamphetamine—Diarrhoea—Indapamide—hypertension	3.84e-05	0.000959	CcSEcCtD
Methamphetamine—Diarrhoea—Diltiazem—hypertension	3.84e-05	0.000959	CcSEcCtD
Methamphetamine—Dizziness—Propranolol—hypertension	3.83e-05	0.000957	CcSEcCtD
Methamphetamine—Insomnia—Hydrochlorothiazide—hypertension	3.83e-05	0.000956	CcSEcCtD
Methamphetamine—Diarrhoea—Carvedilol—hypertension	3.8e-05	0.000949	CcSEcCtD
Methamphetamine—Phenylpropanolamine—SLC6A2—hypertension	3.77e-05	0.0231	CrCbGaD
Methamphetamine—Constipation—Captopril—hypertension	3.77e-05	0.000941	CcSEcCtD
Methamphetamine—Dyspepsia—Perindopril—hypertension	3.77e-05	0.000941	CcSEcCtD
Methamphetamine—Diarrhoea—Doxazosin—hypertension	3.76e-05	0.000939	CcSEcCtD
Methamphetamine—Urticaria—Clonidine—hypertension	3.76e-05	0.000939	CcSEcCtD
Methamphetamine—Dyspepsia—Irbesartan—hypertension	3.75e-05	0.000938	CcSEcCtD
Methamphetamine—CYP2D6—endocrine gland—hypertension	3.74e-05	0.00296	CbGeAlD
Methamphetamine—Palpitations—Ramipril—hypertension	3.73e-05	0.000931	CcSEcCtD
Methamphetamine—Insomnia—Betaxolol—hypertension	3.73e-05	0.00093	CcSEcCtD
Methamphetamine—Dyspepsia—Hydrochlorothiazide—hypertension	3.72e-05	0.00093	CcSEcCtD
Methamphetamine—L-Phenylalanine—TH—hypertension	3.71e-05	0.0227	CrCbGaD
Methamphetamine—Diarrhoea—Fosinopril—hypertension	3.71e-05	0.000927	CcSEcCtD
Methamphetamine—Dizziness—Indapamide—hypertension	3.71e-05	0.000926	CcSEcCtD
Methamphetamine—Dizziness—Diltiazem—hypertension	3.71e-05	0.000926	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Perindopril—hypertension	3.69e-05	0.000923	CcSEcCtD
Methamphetamine—Diarrhoea—Eplerenone—hypertension	3.69e-05	0.000922	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Irbesartan—hypertension	3.68e-05	0.00092	CcSEcCtD
Methamphetamine—Dizziness—Carvedilol—hypertension	3.67e-05	0.000917	CcSEcCtD
Methamphetamine—Urticaria—Trandolapril—hypertension	3.67e-05	0.000915	CcSEcCtD
Methamphetamine—Diarrhoea—Nifedipine—hypertension	3.66e-05	0.000915	CcSEcCtD
Methamphetamine—Constipation—Perindopril—hypertension	3.66e-05	0.000914	CcSEcCtD
Methamphetamine—Hypersensitivity—Valsartan—hypertension	3.66e-05	0.000913	CcSEcCtD
Methamphetamine—Urticaria—Enalapril—hypertension	3.65e-05	0.000912	CcSEcCtD
Methamphetamine—Diarrhoea—Verapamil—hypertension	3.65e-05	0.000911	CcSEcCtD
Methamphetamine—Constipation—Irbesartan—hypertension	3.65e-05	0.000911	CcSEcCtD
Methamphetamine—Palpitations—Timolol—hypertension	3.64e-05	0.00091	CcSEcCtD
Methamphetamine—Dizziness—Doxazosin—hypertension	3.63e-05	0.000907	CcSEcCtD
Methamphetamine—Insomnia—Losartan—hypertension	3.63e-05	0.000907	CcSEcCtD
Methamphetamine—Dyspepsia—Betaxolol—hypertension	3.63e-05	0.000905	CcSEcCtD
Methamphetamine—Constipation—Hydrochlorothiazide—hypertension	3.62e-05	0.000903	CcSEcCtD
Methamphetamine—Diethylpropion—SLC6A3—hypertension	3.61e-05	0.0221	CrCbGaD
Methamphetamine—Urticaria—Telmisartan—hypertension	3.6e-05	0.000899	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Furosemide—hypertension	3.59e-05	0.000897	CcSEcCtD
Methamphetamine—Dizziness—Fosinopril—hypertension	3.59e-05	0.000896	CcSEcCtD
Methamphetamine—Tremor—Lisinopril—hypertension	3.58e-05	0.000895	CcSEcCtD
Methamphetamine—Dizziness—Eplerenone—hypertension	3.57e-05	0.000891	CcSEcCtD
Methamphetamine—Constipation—Furosemide—hypertension	3.56e-05	0.000889	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Betaxolol—hypertension	3.56e-05	0.000888	CcSEcCtD
Methamphetamine—Dizziness—Nifedipine—hypertension	3.54e-05	0.000884	CcSEcCtD
Methamphetamine—Dyspepsia—Losartan—hypertension	3.53e-05	0.000882	CcSEcCtD
Methamphetamine—Dizziness—Verapamil—hypertension	3.53e-05	0.00088	CcSEcCtD
Methamphetamine—Constipation—Betaxolol—hypertension	3.52e-05	0.00088	CcSEcCtD
Methamphetamine—Headache—Diltiazem—hypertension	3.51e-05	0.000878	CcSEcCtD
Methamphetamine—Headache—Indapamide—hypertension	3.51e-05	0.000878	CcSEcCtD
Methamphetamine—Hypersensitivity—Clonidine—hypertension	3.49e-05	0.000871	CcSEcCtD
Methamphetamine—Headache—Carvedilol—hypertension	3.48e-05	0.000869	CcSEcCtD
Methamphetamine—Headache—Doxazosin—hypertension	3.44e-05	0.00086	CcSEcCtD
Methamphetamine—Constipation—Losartan—hypertension	3.43e-05	0.000857	CcSEcCtD
Methamphetamine—Urticaria—Perindopril—hypertension	3.4e-05	0.000849	CcSEcCtD
Methamphetamine—Headache—Fosinopril—hypertension	3.4e-05	0.000849	CcSEcCtD
Methamphetamine—Hypersensitivity—Trandolapril—hypertension	3.4e-05	0.000849	CcSEcCtD
Methamphetamine—Diarrhoea—Valsartan—hypertension	3.4e-05	0.000848	CcSEcCtD
Methamphetamine—Urticaria—Irbesartan—hypertension	3.39e-05	0.000846	CcSEcCtD
Methamphetamine—Hypersensitivity—Enalapril—hypertension	3.39e-05	0.000846	CcSEcCtD
Methamphetamine—Palpitations—Lisinopril—hypertension	3.38e-05	0.000844	CcSEcCtD
Methamphetamine—Diarrhoea—Olmesartan—hypertension	3.38e-05	0.000844	CcSEcCtD
Methamphetamine—Headache—Eplerenone—hypertension	3.38e-05	0.000844	CcSEcCtD
Methamphetamine—CYP2D6—central nervous system—hypertension	3.37e-05	0.00266	CbGeAlD
Methamphetamine—Phentermine—SLC6A2—hypertension	3.36e-05	0.0206	CrCbGaD
Methamphetamine—Urticaria—Hydrochlorothiazide—hypertension	3.36e-05	0.000839	CcSEcCtD
Methamphetamine—Tachycardia—Ramipril—hypertension	3.36e-05	0.000839	CcSEcCtD
Methamphetamine—Headache—Nifedipine—hypertension	3.35e-05	0.000838	CcSEcCtD
Methamphetamine—Headache—Verapamil—hypertension	3.34e-05	0.000834	CcSEcCtD
Methamphetamine—Hypersensitivity—Telmisartan—hypertension	3.34e-05	0.000834	CcSEcCtD
Methamphetamine—Urticaria—Furosemide—hypertension	3.3e-05	0.000825	CcSEcCtD
Methamphetamine—Dizziness—Valsartan—hypertension	3.28e-05	0.00082	CcSEcCtD
Methamphetamine—Urticaria—Betaxolol—hypertension	3.27e-05	0.000817	CcSEcCtD
Methamphetamine—Dizziness—Olmesartan—hypertension	3.27e-05	0.000816	CcSEcCtD
Methamphetamine—Diarrhoea—Clonidine—hypertension	3.24e-05	0.000808	CcSEcCtD
Methamphetamine—Dextroamphetamine—SLC6A2—hypertension	3.21e-05	0.0196	CrCbGaD
Methamphetamine—Urticaria—Losartan—hypertension	3.19e-05	0.000796	CcSEcCtD
Methamphetamine—Pseudoephedrine—SLC6A2—hypertension	3.19e-05	0.0195	CrCbGaD
Methamphetamine—Diarrhoea—Trandolapril—hypertension	3.16e-05	0.000788	CcSEcCtD
Methamphetamine—Diarrhoea—Enalapril—hypertension	3.14e-05	0.000785	CcSEcCtD
Methamphetamine—Hypersensitivity—Irbesartan—hypertension	3.14e-05	0.000785	CcSEcCtD
Methamphetamine—Dizziness—Clonidine—hypertension	3.13e-05	0.000781	CcSEcCtD
Methamphetamine—Hypersensitivity—Hydrochlorothiazide—hypertension	3.12e-05	0.000778	CcSEcCtD
Methamphetamine—Insomnia—Ramipril—hypertension	3.11e-05	0.000777	CcSEcCtD
Methamphetamine—Headache—Valsartan—hypertension	3.11e-05	0.000777	CcSEcCtD
Methamphetamine—Diarrhoea—Telmisartan—hypertension	3.1e-05	0.000775	CcSEcCtD
Methamphetamine—Headache—Olmesartan—hypertension	3.09e-05	0.000773	CcSEcCtD
Methamphetamine—Hypersensitivity—Furosemide—hypertension	3.07e-05	0.000766	CcSEcCtD
Methamphetamine—Dizziness—Trandolapril—hypertension	3.05e-05	0.000762	CcSEcCtD
Methamphetamine—Tachycardia—Lisinopril—hypertension	3.05e-05	0.000761	CcSEcCtD
Methamphetamine—Insomnia—Timolol—hypertension	3.04e-05	0.00076	CcSEcCtD
Methamphetamine—Tolazoline—ADRA1A—hypertension	3.04e-05	0.0186	CrCbGaD
Methamphetamine—Dizziness—Enalapril—hypertension	3.04e-05	0.000759	CcSEcCtD
Methamphetamine—Hypersensitivity—Betaxolol—hypertension	3.03e-05	0.000758	CcSEcCtD
Methamphetamine—Dyspepsia—Ramipril—hypertension	3.03e-05	0.000757	CcSEcCtD
Methamphetamine—Diarrhoea—Captopril—hypertension	3.02e-05	0.000753	CcSEcCtD
Methamphetamine—Dizziness—Telmisartan—hypertension	3e-05	0.000749	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Ramipril—hypertension	2.97e-05	0.000742	CcSEcCtD
Methamphetamine—Headache—Clonidine—hypertension	2.96e-05	0.00074	CcSEcCtD
Methamphetamine—Ephedrine—ADRA1A—hypertension	2.96e-05	0.0181	CrCbGaD
Methamphetamine—Dyspepsia—Timolol—hypertension	2.96e-05	0.00074	CcSEcCtD
Methamphetamine—Hypersensitivity—Losartan—hypertension	2.96e-05	0.000739	CcSEcCtD
Methamphetamine—Constipation—Ramipril—hypertension	2.94e-05	0.000735	CcSEcCtD
Methamphetamine—Diarrhoea—Perindopril—hypertension	2.93e-05	0.000731	CcSEcCtD
Methamphetamine—Diarrhoea—Irbesartan—hypertension	2.92e-05	0.000729	CcSEcCtD
Methamphetamine—Dizziness—Captopril—hypertension	2.91e-05	0.000728	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Timolol—hypertension	2.9e-05	0.000726	CcSEcCtD
Methamphetamine—Diarrhoea—Hydrochlorothiazide—hypertension	2.89e-05	0.000723	CcSEcCtD
Methamphetamine—Headache—Trandolapril—hypertension	2.89e-05	0.000722	CcSEcCtD
Methamphetamine—Headache—Enalapril—hypertension	2.88e-05	0.000719	CcSEcCtD
Methamphetamine—Diarrhoea—Furosemide—hypertension	2.85e-05	0.000711	CcSEcCtD
Methamphetamine—Headache—Telmisartan—hypertension	2.84e-05	0.000709	CcSEcCtD
Methamphetamine—Dizziness—Perindopril—hypertension	2.83e-05	0.000707	CcSEcCtD
Methamphetamine—Insomnia—Lisinopril—hypertension	2.82e-05	0.000705	CcSEcCtD
Methamphetamine—Dizziness—Irbesartan—hypertension	2.82e-05	0.000704	CcSEcCtD
Methamphetamine—Diarrhoea—Betaxolol—hypertension	2.82e-05	0.000704	CcSEcCtD
Methamphetamine—Dizziness—Hydrochlorothiazide—hypertension	2.8e-05	0.000699	CcSEcCtD
Methamphetamine—Headache—Captopril—hypertension	2.76e-05	0.00069	CcSEcCtD
Methamphetamine—Dizziness—Furosemide—hypertension	2.75e-05	0.000687	CcSEcCtD
Methamphetamine—Dyspepsia—Lisinopril—hypertension	2.75e-05	0.000686	CcSEcCtD
Methamphetamine—Diarrhoea—Losartan—hypertension	2.75e-05	0.000686	CcSEcCtD
Methamphetamine—Urticaria—Ramipril—hypertension	2.73e-05	0.000683	CcSEcCtD
Methamphetamine—Lisdexamfetamine—SLC6A3—hypertension	2.73e-05	0.0167	CrCbGaD
Methamphetamine—Dizziness—Betaxolol—hypertension	2.72e-05	0.00068	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Lisinopril—hypertension	2.69e-05	0.000673	CcSEcCtD
Methamphetamine—Headache—Perindopril—hypertension	2.68e-05	0.00067	CcSEcCtD
Methamphetamine—Urticaria—Timolol—hypertension	2.67e-05	0.000668	CcSEcCtD
Methamphetamine—Headache—Irbesartan—hypertension	2.67e-05	0.000667	CcSEcCtD
Methamphetamine—Constipation—Lisinopril—hypertension	2.67e-05	0.000667	CcSEcCtD
Methamphetamine—Nateglinide—KCNJ11—hypertension	2.67e-05	0.0163	CrCbGaD
Methamphetamine—Dexfenfluramine—SLC6A4—hypertension	2.66e-05	0.0163	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRA1A—hypertension	2.66e-05	0.0163	CrCbGaD
Methamphetamine—Dizziness—Losartan—hypertension	2.65e-05	0.000663	CcSEcCtD
Methamphetamine—Headache—Hydrochlorothiazide—hypertension	2.65e-05	0.000662	CcSEcCtD
Methamphetamine—Lacosamide—CA9—hypertension	2.63e-05	0.0161	CrCbGaD
Methamphetamine—Headache—Furosemide—hypertension	2.61e-05	0.000651	CcSEcCtD
Methamphetamine—Amphetamine—SLC6A2—hypertension	2.58e-05	0.0158	CrCbGaD
Methamphetamine—Headache—Betaxolol—hypertension	2.58e-05	0.000644	CcSEcCtD
Methamphetamine—Hypersensitivity—Ramipril—hypertension	2.54e-05	0.000633	CcSEcCtD
Methamphetamine—Headache—Losartan—hypertension	2.51e-05	0.000628	CcSEcCtD
Methamphetamine—Urticaria—Lisinopril—hypertension	2.48e-05	0.000619	CcSEcCtD
Methamphetamine—Hypersensitivity—Timolol—hypertension	2.48e-05	0.000619	CcSEcCtD
Methamphetamine—Benzphetamine—SLC6A2—hypertension	2.38e-05	0.0145	CrCbGaD
Methamphetamine—Diarrhoea—Ramipril—hypertension	2.35e-05	0.000588	CcSEcCtD
Methamphetamine—Diarrhoea—Timolol—hypertension	2.3e-05	0.000575	CcSEcCtD
Methamphetamine—Hypersensitivity—Lisinopril—hypertension	2.3e-05	0.000574	CcSEcCtD
Methamphetamine—Dizziness—Ramipril—hypertension	2.28e-05	0.000568	CcSEcCtD
Methamphetamine—Dextroamphetamine—ADRA1A—hypertension	2.26e-05	0.0138	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRA1A—hypertension	2.24e-05	0.0137	CrCbGaD
Methamphetamine—Dizziness—Timolol—hypertension	2.23e-05	0.000556	CcSEcCtD
Methamphetamine—Headache—Ramipril—hypertension	2.16e-05	0.000539	CcSEcCtD
Methamphetamine—Tolazoline—ADRA2A—hypertension	2.15e-05	0.0132	CrCbGaD
Methamphetamine—Diarrhoea—Lisinopril—hypertension	2.14e-05	0.000533	CcSEcCtD
Methamphetamine—Headache—Timolol—hypertension	2.11e-05	0.000526	CcSEcCtD
Methamphetamine—Dizziness—Lisinopril—hypertension	2.06e-05	0.000516	CcSEcCtD
Methamphetamine—Headache—Lisinopril—hypertension	1.96e-05	0.000488	CcSEcCtD
Methamphetamine—Phenylpropanolamine—SLC6A3—hypertension	1.92e-05	0.0117	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRA2A—hypertension	1.88e-05	0.0115	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRB1—hypertension	1.88e-05	0.0115	CrCbGaD
Methamphetamine—Ephedrine—ADRB2—hypertension	1.76e-05	0.0108	CrCbGaD
Methamphetamine—Phentermine—SLC6A3—hypertension	1.71e-05	0.0105	CrCbGaD
Methamphetamine—Benzphetamine—ADRA1A—hypertension	1.67e-05	0.0102	CrCbGaD
Methamphetamine—Dextroamphetamine—SLC6A3—hypertension	1.63e-05	0.00998	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A3—hypertension	1.62e-05	0.00992	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRA2A—hypertension	1.59e-05	0.00972	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB1—hypertension	1.59e-05	0.00971	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRB2—hypertension	1.58e-05	0.00966	CrCbGaD
Methamphetamine—Pseudoephedrine—TNF—hypertension	1.51e-05	0.00921	CrCbGaD
Methamphetamine—Nateglinide—PPARG—hypertension	1.48e-05	0.00905	CrCbGaD
Methamphetamine—Nateglinide—CYP3A5—hypertension	1.47e-05	0.00901	CrCbGaD
Methamphetamine—Phenelzine—CYP3A5—hypertension	1.45e-05	0.00888	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB2—hypertension	1.33e-05	0.00817	CrCbGaD
Methamphetamine—Amphetamine—SLC6A3—hypertension	1.31e-05	0.00804	CrCbGaD
Methamphetamine—Phentermine—SLC6A4—hypertension	1.28e-05	0.00782	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A4—hypertension	1.21e-05	0.00742	CrCbGaD
Methamphetamine—Benzphetamine—SLC6A3—hypertension	1.21e-05	0.00739	CrCbGaD
Methamphetamine—Benzphetamine—ADRA2A—hypertension	1.18e-05	0.00725	CrCbGaD
Methamphetamine—Benzyl alcohol—CYP1A1—hypertension	1.16e-05	0.00712	CrCbGaD
Methamphetamine—Nateglinide—PTGS1—hypertension	1.09e-05	0.00668	CrCbGaD
Methamphetamine—Amphetamine—SLC6A4—hypertension	9.83e-06	0.00601	CrCbGaD
Methamphetamine—Amphetamine—DRD2—hypertension	9.78e-06	0.00598	CrCbGaD
Methamphetamine—Nateglinide—ALB—hypertension	5.56e-06	0.0034	CrCbGaD
Methamphetamine—ADRA2A—Metabolism—CYP1A1—hypertension	5.86e-07	1.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—hypertension	5.85e-07	1.41e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—EP300—hypertension	5.85e-07	1.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGFR1—hypertension	5.83e-07	1.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCE—hypertension	5.78e-07	1.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CD36—hypertension	5.77e-07	1.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCD—hypertension	5.76e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—hypertension	5.76e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIF1A—hypertension	5.75e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AGT—hypertension	5.72e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VAV3—hypertension	5.71e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDGFA—hypertension	5.71e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CTGF—hypertension	5.71e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3R1—hypertension	5.71e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—hypertension	5.71e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—hypertension	5.7e-07	1.37e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMGCR—hypertension	5.66e-07	1.36e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT2—hypertension	5.66e-07	1.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—hypertension	5.64e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALM1—hypertension	5.63e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFBR2—hypertension	5.63e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—C3—hypertension	5.63e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—hypertension	5.61e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOE—hypertension	5.61e-07	1.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNB3—hypertension	5.58e-07	1.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CAV1—hypertension	5.56e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOA1—hypertension	5.54e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADRA2A—hypertension	5.54e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AVP—hypertension	5.5e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KDR—hypertension	5.49e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PDGFB—hypertension	5.48e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—hypertension	5.47e-07	1.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—hypertension	5.46e-07	1.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RHOA—hypertension	5.45e-07	1.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGFR1—hypertension	5.45e-07	1.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNAS—hypertension	5.43e-07	1.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3R1—hypertension	5.4e-07	1.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—hypertension	5.38e-07	1.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIF1A—hypertension	5.37e-07	1.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARA—hypertension	5.36e-07	1.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—INS—hypertension	5.35e-07	1.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AGT—hypertension	5.35e-07	1.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—hypertension	5.32e-07	1.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOB—hypertension	5.32e-07	1.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTK2—hypertension	5.29e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCB—hypertension	5.29e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—F2—hypertension	5.29e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FN1—hypertension	5.29e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	5.27e-07	1.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALM1—hypertension	5.26e-07	1.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—hypertension	5.24e-07	1.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOE—hypertension	5.24e-07	1.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EDN1—hypertension	5.23e-07	1.26e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—hypertension	5.22e-07	1.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AGT—hypertension	5.19e-07	1.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL5—hypertension	5.19e-07	1.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CAV1—hypertension	5.19e-07	1.25e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TH—hypertension	5.18e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOA1—hypertension	5.18e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH1—hypertension	5.18e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CALM2—hypertension	5.16e-07	1.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KDR—hypertension	5.13e-07	1.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—hypertension	5.12e-07	1.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CALM1—hypertension	5.11e-07	1.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOE—hypertension	5.09e-07	1.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LPL—hypertension	5.08e-07	1.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAV1—hypertension	5.04e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC2A4—hypertension	5.04e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GCG—hypertension	5.04e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—H2AFX—hypertension	5.04e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDGFRB—hypertension	5.03e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	5.03e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOA1—hypertension	5.03e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADCY5—hypertension	4.97e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCB—hypertension	4.94e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FN1—hypertension	4.94e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—F2—hypertension	4.94e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCG—hypertension	4.94e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—hypertension	4.91e-07	1.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ITGB3—hypertension	4.9e-07	1.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCA—hypertension	4.9e-07	1.18e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GOT1—hypertension	4.88e-07	1.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	4.86e-07	1.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH1—hypertension	4.83e-07	1.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—hypertension	4.82e-07	1.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NGF—hypertension	4.81e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPP1—hypertension	4.81e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—INS—hypertension	4.79e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	4.79e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—STK11—hypertension	4.74e-07	1.14e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP19A1—hypertension	4.74e-07	1.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—hypertension	4.71e-07	1.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3R1—hypertension	4.69e-07	1.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—hypertension	4.69e-07	1.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCD—hypertension	4.68e-07	1.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—hypertension	4.68e-07	1.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1—hypertension	4.63e-07	1.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT2—hypertension	4.63e-07	1.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—hypertension	4.61e-07	1.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—hypertension	4.58e-07	1.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C3—hypertension	4.57e-07	1.1e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTEN—hypertension	4.55e-07	1.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—hypertension	4.5e-07	1.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—INS—hypertension	4.48e-07	1.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDGFB—hypertension	4.45e-07	1.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—hypertension	4.43e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGFR1—hypertension	4.43e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COMT—hypertension	4.41e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—hypertension	4.4e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—hypertension	4.4e-07	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—hypertension	4.37e-07	1.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIF1A—hypertension	4.36e-07	1.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—INS—hypertension	4.35e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNB3—hypertension	4.35e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARGC1A—hypertension	4.35e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGT—hypertension	4.34e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—EP300—hypertension	4.34e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1—hypertension	4.33e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT2—hypertension	4.33e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—hypertension	4.33e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—hypertension	4.32e-07	1.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—hypertension	4.31e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—hypertension	4.29e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALM1—hypertension	4.27e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—hypertension	4.27e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGF2—hypertension	4.26e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—hypertension	4.26e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOE—hypertension	4.26e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RHOA—hypertension	4.25e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNAS—hypertension	4.23e-07	1.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CAV1—hypertension	4.22e-07	1.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOA1—hypertension	4.21e-07	1.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3R1—hypertension	4.2e-07	1.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—hypertension	4.2e-07	1.01e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—hypertension	4.18e-07	1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KDR—hypertension	4.17e-07	1e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOB—hypertension	4.14e-07	9.95e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—hypertension	4.11e-07	9.87e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—hypertension	4.03e-07	9.68e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—F2—hypertension	4.01e-07	9.64e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCB—hypertension	4.01e-07	9.64e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FN1—hypertension	4.01e-07	9.64e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—hypertension	3.99e-07	9.57e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGF2—hypertension	3.98e-07	9.56e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RHOA—hypertension	3.97e-07	9.52e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—LPL—hypertension	3.96e-07	9.5e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RELA—hypertension	3.95e-07	9.5e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	3.93e-07	9.43e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—hypertension	3.92e-07	9.43e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3R1—hypertension	3.92e-07	9.43e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MTOR—hypertension	3.88e-07	9.31e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADCY5—hypertension	3.87e-07	9.3e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPX1—hypertension	3.86e-07	9.27e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP1A1—hypertension	3.82e-07	9.18e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PRKCA—hypertension	3.82e-07	9.18e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3R1—hypertension	3.81e-07	9.16e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—hypertension	3.81e-07	9.16e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CD36—hypertension	3.76e-07	9.03e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTEN—hypertension	3.74e-07	8.99e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—hypertension	3.73e-07	8.95e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RELA—hypertension	3.69e-07	8.87e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—hypertension	3.66e-07	8.78e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—INS—hypertension	3.64e-07	8.73e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MTOR—hypertension	3.62e-07	8.7e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—hypertension	3.6e-07	8.65e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—hypertension	3.58e-07	8.59e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—EP300—hypertension	3.57e-07	8.57e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—hypertension	3.56e-07	8.55e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—hypertension	3.54e-07	8.51e-06	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—hypertension	3.54e-07	8.49e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1—hypertension	3.52e-07	8.44e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT2—hypertension	3.51e-07	8.44e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—hypertension	3.5e-07	8.4e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARA—hypertension	3.49e-07	8.39e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—hypertension	3.49e-07	8.37e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—hypertension	3.48e-07	8.36e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AGT—hypertension	3.38e-07	8.13e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—hypertension	3.37e-07	8.1e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—hypertension	3.36e-07	8.08e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1A—hypertension	3.36e-07	8.07e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTEN—hypertension	3.35e-07	8.05e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	3.34e-07	8.02e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CALM1—hypertension	3.33e-07	7.99e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOE—hypertension	3.32e-07	7.96e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—hypertension	3.31e-07	7.95e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAV1—hypertension	3.29e-07	7.89e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK8—hypertension	3.28e-07	7.87e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOA1—hypertension	3.28e-07	7.87e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—hypertension	3.27e-07	7.85e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGF2—hypertension	3.23e-07	7.76e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RHOA—hypertension	3.22e-07	7.74e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EP300—hypertension	3.2e-07	7.68e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—hypertension	3.19e-07	7.66e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	3.19e-07	7.66e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—hypertension	3.15e-07	7.56e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1A—hypertension	3.14e-07	7.54e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTEN—hypertension	3.13e-07	7.52e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SRC—hypertension	3.11e-07	7.46e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK8—hypertension	3.06e-07	7.35e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—hypertension	3.05e-07	7.33e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTEN—hypertension	3.04e-07	7.3e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—hypertension	3.03e-07	7.27e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RELA—hypertension	3e-07	7.21e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EP300—hypertension	2.99e-07	7.17e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MTOR—hypertension	2.94e-07	7.07e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SRC—hypertension	2.9e-07	6.97e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—EP300—hypertension	2.9e-07	6.97e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—hypertension	2.89e-07	6.94e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—hypertension	2.85e-07	6.84e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—INS—hypertension	2.83e-07	6.8e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—hypertension	2.83e-07	6.79e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—hypertension	2.83e-07	6.79e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—hypertension	2.79e-07	6.69e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—hypertension	2.78e-07	6.67e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	2.73e-07	6.56e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—hypertension	2.72e-07	6.54e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—hypertension	2.69e-07	6.46e-06	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—hypertension	2.62e-07	6.3e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—hypertension	2.6e-07	6.25e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—hypertension	2.6e-07	6.24e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—hypertension	2.6e-07	6.23e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—hypertension	2.56e-07	6.14e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	2.55e-07	6.12e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—hypertension	2.54e-07	6.11e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTEN—hypertension	2.54e-07	6.11e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK8—hypertension	2.49e-07	5.97e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—hypertension	2.48e-07	5.97e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3R1—hypertension	2.48e-07	5.97e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—hypertension	2.48e-07	5.96e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EP300—hypertension	2.42e-07	5.82e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SRC—hypertension	2.36e-07	5.66e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—hypertension	2.3e-07	5.52e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—hypertension	2.29e-07	5.49e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—hypertension	2.27e-07	5.46e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—hypertension	2.16e-07	5.18e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—hypertension	2.14e-07	5.13e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—hypertension	2.11e-07	5.08e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—hypertension	2.11e-07	5.06e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—hypertension	2.09e-07	5.03e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—hypertension	2.07e-07	4.96e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTEN—hypertension	1.98e-07	4.76e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—hypertension	1.96e-07	4.7e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—hypertension	1.93e-07	4.64e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—EP300—hypertension	1.89e-07	4.54e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—hypertension	1.8e-07	4.33e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—hypertension	1.75e-07	4.21e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—hypertension	1.74e-07	4.17e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—hypertension	1.59e-07	3.81e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—hypertension	1.47e-07	3.52e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—hypertension	1.14e-07	2.74e-06	CbGpPWpGaD
